4.5 Article

A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

B. Neyns et al.

JOURNAL OF NEURO-ONCOLOGY (2011)

Article Oncology

Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma

David A. Reardon et al.

JOURNAL OF NEURO-ONCOLOGY (2011)

Article Oncology

Bevacizumab for Recurrent Glioblastoma Multiforme: A Meta-Analysis

Eric T. Wong et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2011)

Article Oncology

Salvage chemotherapy with bevacizumab for recurrent alkylator-refractory anaplastic astrocytoma

Marc C. Chamberlain et al.

JOURNAL OF NEURO-ONCOLOGY (2009)

Article Oncology

Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma

James J. Vredenburgh et al.

CLINICAL CANCER RESEARCH (2007)

Article Oncology

Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas

Marjut Puputti et al.

MOLECULAR CANCER RESEARCH (2006)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)